Quest PharmaTech Inc., a publicly traded Canadian pharmaceutical company based in Edmonton, Alberta, specializes in improving the quality of life through its innovative products and technologies. The company has recently announced a significant leadership change. Effective November 23, 2026, Dr. Madi Madiyalakan will become the new Chief Executive Officer (CEO). With a mission centered on leveraging proprietary technologies and partnerships with investee companies, Quest PharmaTech aims to advance its pharmaceutical offerings in the market. This leadership transition comes as the company continues to explore new avenues for growth and development within the pharmaceutical industry, focusing on advancements that could positively impact healthcare outcomes. Further details regarding the strategic direction under Dr. Madiyalakan's leadership will be provided as the transition date approaches.
Analyzed Canadian Outlets (1)
1 headline